Skip to main content
Farhana Latif, MD, Cardiology, New York, NY

FarhanaLatifMD

Cardiology • New York, NY

Heart Failure & Transplantation

Assistant Professor, Medicine, Columbia University College of Phys & Surg

Request Appointment

Overview of Dr. Latif

Dr. Farhana Latif is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Albany Medical College and has been in practice 19 years. She is one of 695 doctors at New York-Presbyterian Hospital and one of 322 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. She has more than 70 publications and over 500 citings.

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)
    Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 2002 - 2007
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1998 - 2001
  • Albany Medical College
    Albany Medical CollegeClass of 1998

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • NY State Medical License
    NY State Medical License 2001 - 2025
  • NJ State Medical License
    NJ State Medical License 2008 - 2009
  • American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Publications & Presentations

PubMed

Journal Articles

  • Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019  
    Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology

Authored Content

  • Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
  • Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
  • Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
  • Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
  • Join now to see all

Dr. Farhana Latif, Dr. Farhana Latif, MD, Dr. F Latif